🇺🇸 FDA
Patent

US 6066323

Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents

expired A61KA61K31/70A61K31/7004

Quick answer

US patent 6066323 (Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents) held by The United States of America as represented by the Secretary of the Army expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/70, A61K31/7004, A61K31/7012, A61K38/00